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ABSTRACT
Introduction: Best disease or vitelliform macular dystrophy is a rare autosomal dominant disorder with 
bilateral presentation characterized by subretinal accumulation of yellowish material in the macular area. 
Macular findings range from a small yellow spot, multiple vitelliform or atrophic lesions to a chorio-retinal 
scar. Case report: A 35 years male presented to our outpatient department with chief complaint of blurring 
of vision of both eyes for the past three months. His visual acuity was 6/12 in both right and left eyes. On 
slit-lamp bio-examination anterior segments of both eyes were normal. On fundus examination, both eyes 
revealed a single, circular, yellow-opaque egg yolk-like macular lesion with no other abnormalities. Optical 
coherence tomography of both eyes revealed deposits of homogenous hyper- reflective material beneath 
retinal pigment epithelium at fovea. Fundus fluorescence angiography showed blocked fluorescence at the 
site of vitelliform lesion of both eyes. Conclusion: Best vitelliform macular dystrophy is a rare genetic 
disorder with incomplete penetrance. Optical coherence tomography and fundus fluorescence angiography 
support the diagnosis.
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INTRODUCTION:
 Inherited macular dystrophies are arbitrarily 
classified on the basis of their tissue of origin into those 
originating from choroid, Bruch’s membrane, retinal 
pigment epithelium (RPE) alone, photoreceptors 
and RPE, and nerve fibre layers. Best disease, also 
termed as vitelliform macular dystrophy, is a separate 
entity among the inherited macular dystrophies. It 
was first reported by Adam and the first pedigree 
was described by Dr. Friedrich Best, a German 
ophthalmologist, in 1905.[1] It is a rare autosomal 
dominant disorder with incomplete penetrance 
and variable expression which typically present in 
childhood involving the long arm of chromosome 11 
(11q12- q13).[1,2,3] Usually the fundus lesions are 
bilateral   (yellow or orange egg-yolk appearance) at 
the macula but can be unilateral. Many individuals 
with Best disease are asymptomatic initially but the 
yellow material is gradually resorbed over time, 
leaving atrophic area of the RPE and often followed 
by subretinal fibrosis. The diagnostic test for Best 
disease is Electrooculogram (EOG) with abnormal 
Arden ratio.  Optical Coherence Tomography 
(OCT), Fundus Fluorescence Angiography (FFA) 
and full-Field Electro-retinograph (ERG) are the 
tests done to support the diagnosis. Here we report a 
case of Best disease with bilateral presentation.
CASE REPORT: 
 A 35 years old male presented to our retina 
department with chief complaint of blurring of 
vision of both eyes for the last three months. There 
were no other complaints. He did not give history 
of any trauma, redness, watering or discharge from 
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either eye. He had no significant past ocular or 
systemic histories. There was no similar history in 
his family members. On examination his presenting 
visual acuity was 6/12 in each eye.
 Visual acuity did not improve even with 
pinhole or best refractive correction. On slit-lamp 
examination, anterior segments of both eyes were 
unremarkable. On posterior segment evaluation, 
fundus of both eyes revealed a normal well- defined 
vertically oval optic disc along with single, yellow or 
orange well-circumscribed dome shaped  egg-yolk 
like sub-retinal  lesion approximately  disc diameter 
in size at macula(Figs. 1a and 1b).
 
Figs 1a and 1b: Right and left fundus showing yellow 
or orange well-circumscribed dome shaped egg-yolk 
like sub-retinal lesion approximately disc diameter 
in size at macula. 
 Intraocular pressure of both the eyes were 
within reference limit. With above history and clinical 
findings Best’s vitelliform macular dystrophy was 
suspected and the patient was investigated with OCT 
and FFA. OCT revealed deposit of homogenous 
hyper-reflective lesion beneath RPE at macula 
showing RPE disruption and thickening suggestive 
of pigment accumulation (Figs. 2a and 2b).   
Figs. 2a and 2b: OCT of both eyes revealed deposit 
of homogenous hyper-reflective lesion beneath 
retinal pigment epithelium at macula showing RPE 
disruption and thickening suggestive of pigment 
accumulation. 
 FFA showed blocked fluorescence at the site 
of vitelliform lesion of both eyes (Figs. 3a and 3b). 
Figs 3a and 3b: Fundus fluorescence angiography 
showed blocked fluorescence at the site of vitelliform 
lesion of both eyes. 
 The EOG and full-field  ERG were not done 
due to unavailability of the test in our hospital. The 
patient was diagnosed as a case of Best vitelliform 
macular dystrophy and advised for follow-up yearly.
DISCUSSION
 Best vitelliform macular dystrophy is a 
rare autosomal dominant disorder of unknown 
prevalence due to the mutation of BEST1 gene with 
incomplete penetrance and variable expression.[2] It 
is characterized by accumulation of heterogeneous 
material between RPE and Bruch’s membrane, 
which is likely derived from the degenerating RPE 
cells containing lipofuscin.[4]  It typically affects 
young patients in whom a macular lesion gradually 
evolves through several characteristic stages. 
 Mohler and Fine classified the evolution of 
Best disease in different stages:[5]
Stage 0:Normal macula with abnormal EOG.
Stage I: Disturbance of the RPE of the macula.
 Stage II: Typical vitelliform or egg yolk lesion.
Stage IIa: Break up of the vitelliform cyst or 
scrambled egg phase. 
Stage III: Pseudo-hypopyon phase where yellow 
material forms a fluid level in the vitelliform cyst.
Stage IVa: Atrophy of pigment epithelium and 
possibly retina produces an orange-red lesion in the 
macula. 
Stage IVb: White hypertrophic scar of fibrous tissue 
in the macula.
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Stage IVc: Neovascularization of the fibrous scar.
 In Best disease mutation in BEST 1 gene 
disturbs the ion transport resulting in acculmulation 
of lipofuscin materials and fluid between RPE and 
photoreceptors.[6]Visual function generally remains 
good until the disease process progresses to cause 
disruption of photoreceptors and RPE and structural 
alterations in the outer retinal layers. Similarly, 
lesions in Best disease are frequently single and 
central but there are few reports which describe 
multiple peripheral lesions outside the macula and 
posterior pole.[7]Best disease could be diagnosed 
clinically but EOG is the diagnostic test for it which 
is abnormal in all stages.
 Other tests such as full field ERG, OCT, 
and FFA are done to support the diagnosis. In our 
case the electrophysiological test was not done due 
to unavailability of test in our hospital. There is no 
definite treatment to slow the progression of this 
disorder. The role of antioxidant supplementation 
in Best disease is of only theoretical benefit.[8] 
The patient of Best disease along with choroidal 
neovascularization should be treated with either 
photodynamic therapy or intra- vitreal anti-vascular 
endothelial growth factors.
CONCLUSION
 Best vitelliform macular dystrophy is a rare 
autosomal dominant disorder. Visual function is 
good in the early stage but gradually decreases in the 
late stage. There is no effective treatment available 
to slow the progression of Best disease. Long term 
follow up is recommended to see the development 
of choroidal neo-vascularisation that may have to be 
treated using intra- vitreal anti-vascular endothelial 
growth factors or photodynamic therapy.
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